PRTC
PureTech Health plc
NASDAQ · Healthcare · Biotechnology · US
$17.38
+2.12%Price chart
Jun 4Jun 9Jun 12Jun 17Jun 23Jun 26Jul 1Jul 17
Key dataJul 17, 2026
Open$16.87
From 52W high−12.40%
Volume9859.00
Market cap$423.06M
P/E (TTM)—
P/S (TTM)91.0x
Div yield—
Key dataJul 17, 2026
Open
$16.87
From 52W high
−12.40%
Volume
9859.00
Market cap
$423.06M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.7x
P/E (TTM)
—
RSI (14)
51.0
MomentumView details →
1D Return
+2.12%
YTD Return
+4.45%
SummaryUpdated Dec 1, 2025
PureTech Health plc (NASDAQ:PRTC) is a clinical-stage biotherapeutics company founded in 2015 and headquartered in Boston, Massachusetts. The company operates through a distinctive "hub-and-spoke" model, where it develops early-stage therapeutic programs internally before spinning them out into independent "Founded Entities" that attract third-party investment. PureTech went public on NASDAQ in November 2020 and has since established itself as a unique player in the biotechnology sector, with a portfolio spanning treatments for neurological disorders, cancer, inflammatory diseases, and rare conditions.
Similar companies
Latest newsMore news →